Find a Tender
complete
Official procurement procedure
(NU/1804) Research Agreement between Newcastle University and Antaros Medical AB
Research laboratory services
Research services
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Newcastle University: "(NU/1804) Research Agreement between Newcastle University and Antaros Medical AB". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Newcastle University | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Newcastle University
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Newcastle University. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
2.4Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 104 active published awards; 98 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNewcastle University | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published23 Aug 2022, 11:17 BST | Last source update23 Aug 2022, 11:17 BST | Recurring procurementNot published |
ClassificationResearch laboratory services, Research services | ||
Delivery area | ||
OCIDocds-h6vhtk-0361f9 | ||
What is being bought
The services required are the analysis of MRI endpoints for a natural history study in subjects with liver disease. Intention to award a research contract under UK Statutory Instrument 2015 No. 102 Part 2 Chapter 2 Section 3 Regulation 32(1)(b)(ii) and (iii) for provision of MRI analysis to support a natural history cohort study in subjects with liver disease. The contracting party will support deployment, acquisition and downstream analysis of MR imaging modalities including but not limited to 2/3D MRE and contrast enhanced MRI, including the use of their own proprietary techniques, to assess liver structure and function and support clinical research.
What changed
From the official release history
- Status changed to complete
23 Aug 2022, 11:17 BST - Official notice release published
23 Aug 2022, 11:17 BST - Buyer information updated
23 Aug 2022, 11:17 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedThe services required are the analysis of MRI endpoints for a natural history study in subjects with liver disease. Intention to award a research contract under UK Statutory Instrument 2015 No. 102 Part 2 Chapter 2 Section 3 Regulation 32(1)(b)(ii) and (iii) for provision of MRI analysis to support a natural history cohort study in subjects with liver disease. The contracting party will support deployment, acquisition and downstream analysis of MR imaging modalities including but not limited to 2/3D MRE and contrast enhanced MRI, including the use of their own proprietary techniques, to assess liver structure and function and support clinical research.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
23 Aug 2022, 11:17 BST - Award active
Not published · Not published - Contract active
Signed 18 Aug 2022, 00:00 BST · Not published
Commercial outcome and competition
Awards Antaros Medical AB Not published · Not published · active |
Contracts (NU/1804) Research Agreement between Newcastle University and Antaros Medical AB Not published · signed 18 Aug 2022, 00:00 BST · active |
Bid statistics highestValidBidValue: 6000000 lowestValidBidValue: 3000000 highestValidBidValue: 6000000 (lot 1) lowestValidBidValue: 3000000 (lot 1) |
Buyer and organisations in this procedure
Newcastle University
Contracting authority GB-FTS-168Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThe intention is to award a research contract under UK Statutory Instrument 2015 No. 102 Part 2 Chapter 2 Section 3 Regulation 32(1)(b)(ii) and (iii). Where (ii) is the justification for technical reasons and (iii) is the protection of exclusive rights, including intellectual property rights. Antaros Medical have established expertise and experience of deploying advanced MR methodologies in studies that seek to investigate not only liver morphology but also downstream consequences of liver fibrosis such as liver function, portal pressure (including pressure effects on the spleen and portal resistive index) and blood flow to the spleen and kidneys. A range of imaging modalities will be employed in this project including but not limited to liver and spleen stiffness using 2/3D MRE and liver function using uptake of MRI contrast agents, where Antaros Medical have developed quantitative modelling of uptake kinetics to assess liver transporter function. Antaros Medical are also developing proprietary PET-tracers targeting Collagen-1 and PDGFRbeta that may be relevant in a future extension of the scope of this project. These tracers are Antaros Medical proprietary investigational products. Antaros medical will support deployment, acquisition and downstream analysis of MR imaging modalities including but not limited to 2/3D MRE and contrast enhanced MRI to assess liver structure and function and support the research project. In addition, Antaros Medical will collaborate as required with the academic investigators to support the downstream analysis of data, sharing know-how of advanced imaging. |